Nahdi Medical Company (TADAWUL: 4164)
Saudi Arabia
· Delayed Price · Currency is SAR 132.40
+1.00 (0.76%)
Sep 12, 2024, 3:19 PM AST
Nahdi Medical Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 9,107 | 8,714 | 8,616 | 8,066 | 8,642 | 7,825 | Upgrade
|
| Revenue Growth (YoY) | 5.49% | 1.13% | 6.82% | -6.66% | 10.45% | 6.46% | Upgrade
|
| Cost of Revenue | 5,662 | 5,278 | 5,141 | 4,821 | 5,448 | 5,361 | Upgrade
|
| Gross Profit | 3,446 | 3,436 | 3,475 | 3,245 | 3,194 | 2,464 | Upgrade
|
| Selling, General & Admin | 2,549 | 2,499 | 2,500 | 2,397 | 2,269 | 1,662 | Upgrade
|
| Other Operating Expenses | -23.16 | -23.7 | -24.3 | -58.06 | -23.08 | -28.86 | Upgrade
|
| Operating Expenses | 2,526 | 2,475 | 2,475 | 2,339 | 2,228 | 1,634 | Upgrade
|
| Operating Income | 919.63 | 960.74 | 999.82 | 905.94 | 966.17 | 830.15 | Upgrade
|
| Interest Expense | -65.73 | -50.46 | -50.47 | -78.88 | -57.5 | -47.76 | Upgrade
|
| Interest & Investment Income | 61.63 | 56.82 | 12.13 | 2.96 | 5.45 | 12.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.91 | 7.91 | 1.8 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -15.01 | -31.47 | -11.15 | 7.61 | 1.8 | -7.59 | Upgrade
|
| EBT Excluding Unusual Items | 908.43 | 943.53 | 952.13 | 837.63 | 915.92 | 787.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.22 | 0.22 | -17.37 | 0.15 | 1.13 | - | Upgrade
|
| Asset Writedown | -0.5 | 0.5 | 3.16 | 19.49 | -22.6 | -18.42 | Upgrade
|
| Pretax Income | 908.15 | 944.25 | 937.93 | 857.27 | 894.45 | 768.63 | Upgrade
|
| Income Tax Expense | 44.14 | 51.63 | 50.11 | 44.74 | 45.33 | 76.63 | Upgrade
|
| Net Income | 864.01 | 892.62 | 887.81 | 812.53 | 849.12 | 692 | Upgrade
|
| Net Income to Common | 864.01 | 892.62 | 887.81 | 812.53 | 849.12 | 692 | Upgrade
|
| Net Income Growth | -3.04% | 0.54% | 9.27% | -4.31% | 22.70% | 13.32% | Upgrade
|
| Shares Outstanding (Basic) | 130 | 130 | 130 | 130 | 130 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 130 | 130 | 130 | 130 | 130 | 5 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 2500.00% | - | Upgrade
|
| EPS (Basic) | 6.65 | 6.87 | 6.83 | 6.25 | 6.53 | 138.40 | Upgrade
|
| EPS (Diluted) | 6.65 | 6.87 | 6.83 | 6.25 | 6.53 | 138.40 | Upgrade
|
| EPS Growth | -3.04% | 0.54% | 9.27% | -4.31% | -95.28% | 13.32% | Upgrade
|
| Free Cash Flow | 953.66 | 1,015 | 1,418 | 1,051 | 1,290 | 1,130 | Upgrade
|
| Free Cash Flow Per Share | 7.34 | 7.81 | 10.90 | 8.09 | 9.92 | 226.02 | Upgrade
|
| Dividend Per Share | 5.500 | 5.500 | 5.310 | - | - | - | Upgrade
|
| Dividend Growth | 0% | 3.58% | - | - | - | - | Upgrade
|
| Gross Margin | 37.83% | 39.43% | 40.33% | 40.23% | 36.96% | 31.49% | Upgrade
|
| Operating Margin | 10.10% | 11.03% | 11.60% | 11.23% | 11.18% | 10.61% | Upgrade
|
| Profit Margin | 9.49% | 10.24% | 10.30% | 10.07% | 9.83% | 8.84% | Upgrade
|
| Free Cash Flow Margin | 10.47% | 11.65% | 16.45% | 13.03% | 14.93% | 14.44% | Upgrade
|
| EBITDA | 1,158 | 1,181 | 1,192 | 1,070 | 1,110 | 963.49 | Upgrade
|
| EBITDA Margin | 12.71% | 13.55% | 13.84% | 13.26% | 12.84% | 12.31% | Upgrade
|
| D&A For EBITDA | 238.04 | 219.86 | 192.36 | 164.03 | 143.75 | 133.34 | Upgrade
|
| EBIT | 919.63 | 960.74 | 999.82 | 905.94 | 966.17 | 830.15 | Upgrade
|
| EBIT Margin | 10.10% | 11.03% | 11.60% | 11.23% | 11.18% | 10.61% | Upgrade
|
| Effective Tax Rate | 4.86% | 5.47% | 5.34% | 5.22% | 5.07% | 9.97% | Upgrade
|
| Advertising Expenses | - | 66.36 | 67.81 | 54.92 | 75.69 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.